These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34786256)

  • 1. A Case of Hepatitis B Virus Reactivation Triggered by Acute Epstein-Barr Virus Infection.
    Beran A; Mhanna M; Haghbin H; Sample JW; Burlen J
    Cureus; 2021 Oct; 13(10):e18676. PubMed ID: 34786256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome.
    Rao SC; Ashraf I; Mir F; Samiullah S; Ibdah JA; Tahan V
    Am J Case Rep; 2017 Feb; 18():170-172. PubMed ID: 28202897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report.
    Schultze D; Mani B; Dollenmaier G; Sahli R; Zbinden A; Krayenbühl PA
    BMC Infect Dis; 2015 Oct; 15():474. PubMed ID: 26511098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation.
    Hu J; Zhao J; Wang C; Jia M; Su M; Li S
    Ann Hematol; 2023 Dec; 102(12):3593-3601. PubMed ID: 37831153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma.
    Kwong S; Lu X; Liu X; Lai J
    Gastroenterology Res; 2020 Apr; 13(2):81-84. PubMed ID: 32362967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure.
    Hu J; Zhao H; Lou D; Gao H; Yang M; Zhang X; Jia H; Li L
    BMC Infect Dis; 2018 Nov; 18(1):577. PubMed ID: 30445927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study.
    Tsai YF; Yang CI; Du JS; Lin MH; Tang SH; Wang HC; Cho SF; Liu YC; Su YC; Dai CY; Hsiao HH
    PeerJ; 2019; 7():e7481. PubMed ID: 31565551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis.
    Da Cunha T; Mago S; Bath RK
    Cureus; 2022 Apr; 14(4):e24552. PubMed ID: 35664414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of hepatitis B viral infection in Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Xu T; Huang Z; Deng Y; Wang S; Su B; Wei W; Wang D; Jiang J; Li A; Zhang G; Yang H; Claret FX; Hu W
    J Clin Virol; 2015 Mar; 64():64-71. PubMed ID: 25728081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polyclonal activation due to Epstein-Barr virus superinfection in a case with chronic hepatitis B].
    Bakir Ozbey S; Mistik R; Gürcüoğlu E; Oral B; Göral G
    Mikrobiyol Bul; 2007 Oct; 41(4):607-12. PubMed ID: 18173082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Epstein-Barr virus in B cells of patients with chronic hepatitis C.
    Shimozuma Y; Ito T; Inokuchi M; Uchikoshi M; Miyashita M; Nozawa H; Shimazaki T; Hiroishi K; Imawari M
    J Med Virol; 2010 Dec; 82(12):2064-72. PubMed ID: 20981794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
    Simpson ND; Simpson PW; Ahmed AM; Nguyen MH; Garcia G; Keeffe EB; Ahmed A
    J Clin Gastroenterol; 2003 Jul; 37(1):68-71. PubMed ID: 12811213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses.
    Sinha M; Rao CR; Premalata CS; Shafiulla M; Lakshmaiah KC; Jacob LA; Babu GK; Viveka BK; Appaji L; Subramanyam JR
    Indian J Med Paediatr Oncol; 2016; 37(3):146-51. PubMed ID: 27688607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Epstein-Barr virus, hepatitis B virus, hepatitis C virus, and human immunodeficiency virus among patients with non-Hodgkin's lymphoma at the Yaounde General Hospital, Cameroon.
    Bikoï JN; Ndedi EDFM; Okobalemba EA; Mbaga DS; Mikangue CAM; Membangbi AE; Nguiffo EM; Essindi JO; Mondinde GI; Essama SHR
    Pan Afr Med J; 2022; 42():58. PubMed ID: 35949454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus Hepatitis Masquerading as Painless Jaundice.
    Adelodun A; Abdellatief A; Babajide O
    Cureus; 2022 Oct; 14(10):e30333. PubMed ID: 36407142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review.
    Miyasaka A; Yoshida Y; Suzuki A; Masuda T; Okamoto H; Takikawa Y
    Medicine (Baltimore); 2020 Oct; 99(41):e22650. PubMed ID: 33031326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Presentation of Epstein-Barr Virus Infection.
    Teijido J; Tillotson K; Liu JM
    J Emerg Med; 2020 Feb; 58(2):e71-e73. PubMed ID: 31973958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation in Niigata Rheumatic Center.
    Ito S
    Mod Rheumatol; 2021 Jul; 31(4):775-782. PubMed ID: 33021133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
    Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.